ORR (Objective Response Rate) and related statistics – Part 1
Efficacy | Tivdak® (tisotumab vedotin-tftv)
Durable Response Rate
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Objective response rate of placebo in randomized controlled trials of anticancer medicines - eClinicalMedicine
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
Efficacy Data | KYMRIAH® (tisagenlecleucel) for DLBCL | HCP
Cell therapy doubles survival, response rates in advanced melanoma
Efficacy I PLUVICTO
What Low Response Rates Mean for Telephone Surveys | Pew Research Center
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates | JCO Clinical Cancer Informatics
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Best Overall Response Rate (full analysis population) | Download Table
Durable Response Rate
Efficacy - Overall Response Rate | Aliqopa US HCP
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
Objective response rate assessment in oncology: Current situation and future expectations
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial | Nature Medicine
Efficacy | BALVERSA® (erdafitinib) HCP
Efficacy endpoints in Oncology
